Not applicableLooking for participantsNCT07071649
What this trial is testing
Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers
Who this might be right for
Alzheimer's DiseaseBiomarkersNon-invasive Diagnosis+1 more
Centre Hospitalier Universitaire, Amiens 40